Study S001748

Effects of Liraglutide on Cardio-Metabolic Risk Markers

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01715428
Study type: OBSERVATIONAL
Status: COMPLETED
Enrollment: 300
Start: 2012-06
Primary completion: 2015-12
Lead sponsor: University of Palermo
Conditions: Type-2 Diabetes
Results posted: FALSE

Registered primary outcomes

carotid intima-media thickness [every four months for a total period of 2 years]

Linked records (6)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0015536	Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study. Nikolic D, Diabetes therapy : research, treatment and education of diabetes and related disorders	2022	Nonrandomized study	PMID 35167051 DOI	cites ClinicalTrials.gov:NCT01715428; registry reference DERIVED:35167051
R0017282	Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect. Nikolic D, Diabetes therapy : research, treatment and education of diabetes and related disorders	2021	Nonrandomized study	PMID 33210276 DOI	cites ClinicalTrials.gov:NCT01715428; registry reference DERIVED:33210276
R0018306	Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study. Rizzo M, Cardiovascular diabetology	2016	Nonrandomized study	PMID 27912784 DOI	cites ClinicalTrials.gov:NCT01715428; registry reference DERIVED:27912784
R0023219	Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study. Rizzo M, The Journal of clinical endocrinology and metabolism	2015	Other trial	PMID 25393640 DOI	cites ClinicalTrials.gov:NCT01715428; registry reference DERIVED:25393640
R0026753	Liraglutide improves carotid intima-media thickness in patients with type 2 diabetes and non-alcoholic fatty liver disease: an 8-month prospective pilot study. Rizvi AA, Expert opinion on biological therapy	2015	Other trial	PMID 26195184 DOI	cites ClinicalTrials.gov:NCT01715428; registry reference DERIVED:26195184
R0023771	Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study. Rizzo M, Cardiovascular diabetology	2014	Other trial	PMID 24559258 DOI	cites ClinicalTrials.gov:NCT01715428; registry reference DERIVED:24559258